Philips iX is scalable and supports a shared IT infrastructure among different departments. Clinicians can view monitoring history, from the ED to telemetry floors and during transport, and multiple security mechanisms, including user authentication and authorization, protect data integrity and confidentiality. It also has end-to-end clinical data analytics capabilities for high-resolution physiologic data acquisition, archiving, and access.

Also scalable, healthcare providers can continue adding new types of medical devices with Philips Capsule MDIP, which monitors, aggregates, and compiles data in a single interface that enables better prioritization and coordination of interventions. Additionally, NYU Langone Health will adopt Philips’ IntelliSite Pathology solution, for open and scalable pathology-based IT infrastructures and workflows; enterprise informatics; and AI-enabled diagnostic imaging technologies such as the Philips Lumify Handheld Ultrasound.


“Our access to transformative healthcare technologies developed by Philips will provide our researchers with countless opportunities to advance knowledge and develop new diagnostic and treatment modalities that enhance patient care, safety, and outcomes,” said NYU Langone’s chief scientific officer, executive vice president, and vice dean for Science Dr. Dafna Bar-Sagi, in a statement.

Back to HCB News

Business Affairs Homepage